News
ICU ▲ +9.6% - SeaStar Medical Holding Corporation
ICU ▲ +9.6% - SeaStar Medical Holding Corporation
$ICU - FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients
03-NOV-2026 08:21 AM ET
Share this post
More filings for $ICU
ICU ▲ +2.5% - SeaStar Medical Holding CorporationOct 22, 2026ICU ▼ -4.7% - SeaStar Medical Holding CorporationOct 14, 2026ICU ▲ +3.1% - SeaStar Medical Holding CorporationOct 7, 2026ICU ▼ -5.3% - SeaStar Medical Holding CorporationOct 5, 2026ICU ▲ +0.5% - SeaStar Medical Holding CorporationOct 2, 2026ICU ▲ +1.8% - SeaStar Medical Holding CorporationOct 1, 2026
View full $ICU filing history →💬 Comments
Loading comments…
Leave a comment